Strategies for discovering novel cancer biomarkers through utilization of emerging technologies, Nat Clin Pract Oncol, vol.5, pp.588-99, 2008. ,
Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery, Expert Opin Med Diagn, vol.7, pp.327-371, 2004. ,
Advances in the proteomic investigation of the cell secretome, Expert Rev Proteomics, vol.9, pp.337-382, 2012. ,
Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach, Mol Cell Proteomics, vol.5, pp.157-71, 2006. ,
Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling, J Proteomics, vol.99, pp.26-39, 2014. ,
Interstitial fluid-a reflection of the tumor cell microenvironment and secretome, Biochim Biophys Acta, vol.1834, pp.2336-2382, 2013. ,
The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context, Biochim Biophys Acta, vol.1834, pp.2242-58, 2013. ,
Ultraslow microdialysis and microfiltration for in-line, on-line and off-line monitoring, Trends Biotechnol, vol.28, pp.150-158, 2010. ,
In vivo tumor secretion probing via ultrafiltration and tissue chamber: implication for anti-cancer drugs targeting secretome, Recent Pat Anticancer Drug Discov, vol.3, pp.48-54, 2008. ,
Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses, Proteomics, vol.6, pp.6107-6123, 2006. ,
Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle, Expert Opin Biol Ther, vol.15, pp.103-120, 2015. ,
Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer, Cancer Gene Ther, 2016. ,
Circulating tumor DNA as a liquid biopsy for cancer, Clin Chem, vol.61, pp.112-135, 2015. ,
Circulating tumour cells and circulating nucleic acids as a measure of tumour dissemination in non-metastatic colorectal cancer surgery, Eur J Surg Oncol, vol.41, pp.309-323, 2015. ,
Microsatellite instability and colorectal cancer prognosis, Clin Cancer Res, vol.11, pp.8332-8372, 2005. ,
The genomic era of clinical oncology: integrated genomic analysis for precision cancer care, Cytogenet Genome Res, 2016. ,
Good laboratory practice for clinical next-generation sequencing informatics pipelines, Nat Biotechnol, vol.33, pp.689-93, 2015. ,
Nextgeneration sequencing in clinical molecular diagnostics of cancer: advantages and challenges, Cancers (Basel), vol.7, pp.2023-2059, 2015. ,
Metabolomics: beyond biomarkers and towards mechanisms, Nat Rev Mol Cell Biol, vol.17, pp.451-460, 2016. ,
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution, Cancer Cell, vol.27, pp.15-26, 2015. ,
Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ, Mol Cell Proteomics, vol.13, pp.2513-2539, 2014. ,
Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer, Oncogene, 2016. ,
TM4 microarray software suite, Methods Enzymol, vol.411, issue.06, pp.11009-11014, 2006. ,
Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes, Oncotarget, 2016. ,
Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer, Oncotarget, vol.6, pp.10253-66, 2015. ,
Quasimonomorphic mononucleotide repeats for highlevel microsatellite instability analysis, Dis Markers, vol.20, pp.251-258, 2004. ,
Sensitive sequencing method for KRAS mutation detection by Pyrosequencing, J Mol Diagn, vol.7, issue.10, pp.60571-60576, 2005. ,